(Q84528309)
Statements
Potent graft-versus-leukemia effect after reduced-intensity allogeneic SCT for intermediate-risk AML with FLT3-ITD or wild-type NPM1 and CEBPA without FLT3-ITD (English)
Gaëlle Labouré
Stéphanie Dulucq
Reza Tabrizi
Estelle Guérin
Arnaud Pigneux
Xavier Lafarge
Thibaut Leguay
Krimo Bouabdallah
Marie-Sarah Dilhuydy
Cédric Duclos
Axelle Lascaux
Gérald Marit
François-Xavier Mahon
Jean-Michel Boiron
Stéphane Vigouroux